(Q34521435)

2 August 2017

title

Evaluation of Cladribine treatment in refractory celiac disease type II. (English)

1 reference

2 August 2017

Greetje J Tack

1

1 reference

2 August 2017

Wieke H M Verbeek

2

1 reference

2 August 2017

Abdul Al-Toma

3

1 reference

2 August 2017

Dirk J Kuik

4

1 reference

2 August 2017

Marco W J Schreurs

5

1 reference

2 August 2017

Otto Visser

6

1 reference

2 August 2017

Chris J J Mulder

7

1 reference

2 August 2017

language of work or name

English

0 references

publication date

1 January 2011

1 reference

World Journal of Gastroenterology

2 August 2017

published in

1 reference

2 August 2017

volume

17

1 reference

2 August 2017

issue

4

1 reference

2 August 2017

page(s)

506-513

1 reference

A placebo-controlled trial of oral cladribine for relapsing multiple sclerosis

2 August 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3027018

Presentation and long-term follow-up of refractory celiac disease: comparison of type I with type II.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3027018

Clinical staging and survival in refractory celiac disease: a single center experience

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3027018

Older and new formulations of cladribine. Pharmacology and clinical efficacy in hematological malignancies

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3027018

Small bowel capsule endoscopy in 2007: indications, risks and limitations

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3027018

Flow cytometric determination of aberrant intra-epithelial lymphocytes predicts T-cell lymphoma development more accurately than T-cell clonality analysis in Refractory Celiac Disease

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3027018

Survival in refractory coeliac disease and enteropathy-associated T-cell lymphoma: retrospective evaluation of single-centre experience

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3027018

Abdominal computed tomography in refractory coeliac disease and enteropathy associated T-cell lymphoma

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3027018

Purine analogues: rationale for development, mechanisms of action, and pharmacokinetics in hairy cell leukemia

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3027018

Cladribine therapy in refractory celiac disease with aberrant T cells

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3027018

Refractory coeliac disease

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3027018

Azathioprine and prednisone combination therapy in refractory coeliac disease

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3027018

Refractory sprue, coeliac disease, and enteropathy-associated T-cell lymphoma. French Coeliac Disease Study Group.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3027018

Molecular basis of celiac disease

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3027018

18F-FDG PET versus CT for the detection of enteropathy-associated T-cell lymphoma in refractory celiac disease.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3027018

Intestinal non-Hodgkin's lymphoma: a multicenter prospective clinical study from the German Study Group on Intestinal non-Hodgkin's Lymphoma

27 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3027018

Refractory sprue syndrome with clonal intraepithelial lymphocytes evolving into overt enteropathy-type intestinal T-cell lymphoma

27 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3027018

A limited sampling strategy for estimation of the cladribine plasma area under the concentration versus time curve after intermittent i.v. infusion, s.c. injection, and oral administration.

27 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3027018

Aberrant T-lymphocytes in refractory coeliac disease are not strictly confined to a small intestinal intraepithelial localization

27 October 2018

1 reference

12 December 2020

The value of double-balloon enteroscopy in patients with refractory celiac disease

1 reference

12 December 2020

Novel approaches in the management of refractory celiac disease

1 reference

12 December 2020

Sensitivity of antiendomysium and antigliadin antibodies in untreated celiac disease: disappointing in clinical practice

1 reference

12 December 2020

Auto-SCT in refractory celiac disease type II patients unresponsive to cladribine therapy

1 reference

12 December 2020

1 reference

12 December 2020

Combination chemotherapy followed by autologous stem cell transplant for enteropathy-associated T cell lymphoma

1 reference

12 December 2020

Identifiers

DOI

10.3748/WJG.V17.I4.506

1 reference

2 August 2017

1 reference

2 August 2017

1 reference